Healthcare provider profile · identity verified

Frank A Crociata, DO

Family Practice · TORRINGTON, CT · NPI 1497790711

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	656	167
Lisinopril	Lisinopril	408	102
Amlodipine Besylate	Amlodipine Besylate	326	75
Levothyroxine Sodium	Levothyroxine Sodium	269	55
Pantoprazole Sodium	Pantoprazole Sodium	254	71
Losartan Potassium	Losartan Potassium	239	66
Fluticasone Propionate	Fluticasone Propionate	185	74
Gabapentin	Gabapentin	183	31
Tamsulosin Hcl	Tamsulosin Hcl	183	38
Rosuvastatin Calcium	Rosuvastatin Calcium	179	42
Hydrochlorothiazide	Hydrochlorothiazide	166	42
Metoprolol Succinate	Metoprolol Succinate	166	40
Metformin Hcl	Metformin Hcl	165	39
Albuterol Sulfate Hfa	Albuterol Sulfate	133	40
Omeprazole	Omeprazole	132	30
Famotidine	Famotidine	128	35
Ozempic	Semaglutide	120	18
Furosemide	Furosemide	117	29
Escitalopram Oxalate	Escitalopram Oxalate	114	27
Glimepiride	Glimepiride	114	17
Potassium Chloride	Potassium Chloride	111	21
Pregabalin	Pregabalin	107	23
Shingrix	Varicella-Zoster Ge/As01b/Pf	106	73
Buspirone Hcl	Buspirone Hcl	104	18
Tramadol Hcl	Tramadol Hcl	103	22
Sertraline Hcl	Sertraline Hcl	101	23
Eliquis	Apixaban	91	17
Zolpidem Tartrate	Zolpidem Tartrate	90	13
Pravastatin Sodium	Pravastatin Sodium	88	19
Metoprolol Tartrate	Metoprolol Tartrate	84	17
Duloxetine Hcl	Duloxetine Hcl	80	suppressed
Allopurinol	Allopurinol	79	19
Januvia	Sitagliptin Phosphate	76	14
Ropinirole Hcl	Ropinirole Hcl	65	11
Trazodone Hcl	Trazodone Hcl	64	19
Baclofen	Baclofen	63	11
Bupropion Xl	Bupropion Hcl	60	11
Clopidogrel	Clopidogrel Bisulfate	50	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	suppressed
Montelukast Sodium	Montelukast Sodium	47	suppressed
Ezetimibe	Ezetimibe	46	11
Carvedilol	Carvedilol	45	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	45	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	33
Alendronate Sodium	Alendronate Sodium	42	12
Telmisartan	Telmisartan	42	suppressed
Lovastatin	Lovastatin	40	suppressed
Prednisone	Prednisone	39	24
Atenolol	Atenolol	37	suppressed
Primidone	Primidone	37	suppressed
Alprazolam	Alprazolam	36	18
Linzess	Linaclotide	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Topiramate	Topiramate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	23
Citalopram Hbr	Citalopram Hydrobromide	35	11
Colchicine	Colchicine	35	11
Ibuprofen	Ibuprofen	35	14
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	33	suppressed
Doxepin Hcl	Doxepin Hcl	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Nystatin	Nystatin	31	14
Simvastatin	Simvastatin	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Meloxicam	Meloxicam	30	suppressed
Azithromycin	Azithromycin	29	15
Fludrocortisone Acetate	Fludrocortisone Acetate	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	29	suppressed
Finasteride	Finasteride	28	suppressed
Methenamine Hippurate	Methenamine Hippurate	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Nabumetone	Nabumetone	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	11
Celecoxib	Celecoxib	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Naltrexone Hcl	Naltrexone Hcl	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Febuxostat	Febuxostat	21	suppressed
Indapamide	Indapamide	21	suppressed
Nyamyc	Nystatin	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Methimazole	Methimazole	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Lorazepam	Lorazepam	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Glipizide	Glipizide	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cephalexin	Cephalexin	14	11
Testosterone	Testosterone	14	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Ramipril	Ramipril	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Naproxen	Naproxen	12	suppressed
Torsemide	Torsemide	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ropinirole Er	Ropinirole Hcl	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error